Rezo is a different kind of biopharma company. Our mission is to dramatically increase the success rate of drug development by building a disease-agnostic, fully-integrated, network biology platform that will redefine our understanding of human disease and ability to treat it.
Our Founders and members of the Board are a group of esteemed, world-class scientists from the University of California, San Francisco: Nevan Krogan, Kevan Shokat, Sourav Bandyopadhyay, Natalia Jura, as well as renowned biotech executives George Scangos and Norbert Bischofberger. These leaders bring with them a strong track record of amazing discoveries and scientific breakthroughs, leading to very successful companies and many FDA approved drugs.
Location: United States, California, San Francisco
Member count: 1-10
Total raised: $78M
Investors 3
| Date | Name | Website |
| - | Norwest Ve... | nvp.com |
| - | Hawktail M... | hawktail.c... |
| 27.11.2022 | SR One | srone.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 17.11.2022 | Series A | $78M | a16z | - |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 22.11.2022 | Rezo Thera... | Rezo Therapeutics, San Francis... | USA | - | finsmes.co... |
| - | Rezo Thera... | “Rezo is pioneering an integra... | - | - | fastfounde... |